Author Correction: HER Kinase Inhibition in Patients with HER2- and HER3-mutant Cancers

Overview

Journal Nature

Specialty Science

Date 2019 Feb 14

PMID 30755741

Citations 5

Authors

David M Hyman

Sarina A Piha-Paul

Helen Won

Jordi Rodon

Cristina Saura

Geoffrey I Shapiro

Dejan Juric

David I Quinn

Victor Moreno

Bernard Doger

Ingrid A Mayer

Valentina Boni

Emiliano Calvo

Sherene Loi

Albert C Lockhart

Joseph P Erinjeri

Maurizio Scaltriti

Gary A Ulaner

Juber Patel

Jiabin Tang

Hannah Beer

S Duygu Selcuklu

Aphrothiti J Hanrahan

Nancy Bouvier

Myra Melcer

Rajmohan Murali

Alison M Schram

Lillian M Smyth

Komal Jhaveri

Bob T Li

Alexander Drilon

James J Harding

Gopa Iyer

Barry S Taylor

Michael F Berger

Richard E Cutler Jr

Feng Xu

Anna Butturini

Lisa D Eli

Grace Mann

Cynthia Farrell

Alshad S Lalani

Richard P Bryce

Carlos L Arteaga

Funda Meric-Bernstam

Jose Baselga

David B Solit

Affiliations

Soon will be listed here.

Abstract

The 'Competing interests' statement of this Article has been updated; please see the accompanying Amendment. The original Article has not been corrected online.

Citing Articles

Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2.

Liu Y, Bischof E, Chen Z, Zhou J, Zhang B, Zhang D Oncol Res. 2024; 32(9):1429-1438.

PMID: 39220126 PMC: 11361911. DOI: 10.32604/or.2024.047309.

Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer.

Rupp B, Owen S, Ball H, Smith K, Gunchick V, Keller E Int J Mol Sci. 2022; 23(14).

PMID: 35887203 PMC: 9316651. DOI: 10.3390/ijms23147852.

Negative Ultraselection of Patients With / Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy.

Randon G, Maddalena G, Germani M, Pircher C, Manca P, Bergamo F JCO Precis Oncol. 2022; 6:e2200037.

PMID: 35544729 PMC: 9200389. DOI: 10.1200/PO.22.00037.

Efficacy of targeted therapy in patients with HER2-positive non-small cell lung cancer: A systematic review and meta-analysis.

Wu H, Zhuo K, Wang K Br J Clin Pharmacol. 2021; 88(5):2019-2034.

PMID: 34820879 PMC: 9302639. DOI: 10.1111/bcp.15155.

Genomic Characterization of -Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine.

Mondaca S, Razavi P, Xu C, Offin M, Myers M, Scaltriti M JCO Precis Oncol. 2020; 3.

PMID: 32923849 PMC: 7446346. DOI: 10.1200/PO.19.00223.